These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15001446)

  • 1. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
    Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
    Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
    Blanchard E; Seidman C; Seidman JG; LeWinter M; Maughan D
    Circ Res; 1999 Mar; 84(4):475-83. PubMed ID: 10066683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
    Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
    J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.
    Lowey S; Bretton V; Gulick J; Robbins J; Trybus KM
    J Biol Chem; 2013 May; 288(21):14780-7. PubMed ID: 23580644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
    Witjas-Paalberends ER; Ferrara C; Scellini B; Piroddi N; Montag J; Tesi C; Stienen GJ; Michels M; Ho CY; Kraft T; Poggesi C; van der Velden J
    J Physiol; 2014 Aug; 592(15):3257-72. PubMed ID: 24928957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.
    Tyska MJ; Hayes E; Giewat M; Seidman CE; Seidman JG; Warshaw DM
    Circ Res; 2000 Apr; 86(7):737-44. PubMed ID: 10764406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
    Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
    Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
    J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
    Palmiter KA; Tyska MJ; Haeberle JR; Alpert NR; Fananapazir L; Warshaw DM
    J Muscle Res Cell Motil; 2000; 21(7):609-20. PubMed ID: 11227787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.
    Ujfalusi Z; Vera CD; Mijailovich SM; Svicevic M; Yu EC; Kawana M; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2018 Jun; 293(23):9017-9029. PubMed ID: 29666183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.
    Belus A; Piroddi N; Scellini B; Tesi C; D'Amati G; Girolami F; Yacoub M; Cecchi F; Olivotto I; Poggesi C
    J Physiol; 2008 Aug; 586(15):3639-44. PubMed ID: 18565996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function.
    Sommese RF; Sung J; Nag S; Sutton S; Deacon JC; Choe E; Leinwand LA; Ruppel K; Spudich JA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12607-12. PubMed ID: 23798412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac β-myosin.
    Bloemink M; Deacon J; Langer S; Vera C; Combs A; Leinwand L; Geeves MA
    J Biol Chem; 2014 Feb; 289(8):5158-67. PubMed ID: 24344137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
    Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
    Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
    Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
    Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.